We are live on ! Find out more
ATRC icon

AtriCure

223 hedge funds and large institutions have $1.7B invested in AtriCure in 2025 Q3 according to their latest regulatory filings, with 34 funds opening new positions, 70 increasing their positions, 82 reducing their positions, and 11 closing their positions.

New
Increased
Maintained
Reduced
Closed

209% more first-time investments, than exits

New positions opened: 34 | Existing positions closed: 11

11% more funds holding

Funds holding: 201223 (+22)

6% more capital invested

Capital invested by funds: $1.6B → $1.7B (+$94.6M)

1.93% less ownership

Funds ownership: 98.81%96.88% (-1.9%)

15% less repeat investments, than reductions

Existing positions increased: 70 | Existing positions reduced: 82

50% less funds holding in top 10

Funds holding in top 10: 21 (-1)

Holders
223
Holders Change
+22
Holders Change %
+10.95%
% of All Funds
2.93%
Holding in Top 10
1
Holding in Top 10 Change
-1
Holding in Top 10 Change %
-50%
% of All Funds
0.01%
New
34
Increased
70
Reduced
82
Closed
11
Calls
$1.52M
Puts
Net Calls
+$1.52M
Net Calls Change
+$421K
Name Holding Trade Value Shares
Change
Change in
Stake
SG Americas Securities
101
SG Americas Securities
New York
$824K -$925K -26,861 -53%
ACM
102
Aquatic Capital Management
Illinois
$811K +$793K +23,015 New
Janus Henderson Group
103
Janus Henderson Group
United Kingdom
$807K
Manulife (Manufacturers Life Insurance)
104
Manulife (Manufacturers Life Insurance)
Ontario, Canada
$798K -$59.7K -1,734 -7%
Mirae Asset Global ETFs Holdings
105
Mirae Asset Global ETFs Holdings
Hong Kong
$789K -$143K -4,136 -16%
Ameriprise
106
Ameriprise
Minnesota
$772K +$754K +21,889 New
Truist Financial
107
Truist Financial
North Carolina
$739K -$8.48K -246 -1%
IIM
108
INTECH Investment Management
Florida
$713K -$301K -8,741 -30%
Focus Partners Wealth
109
Focus Partners Wealth
Massachusetts
$691K +$62.8K +1,824 +10%
LPL Financial
110
LPL Financial
California
$634K +$161K +4,685 +35%
Verition Fund Management
111
Verition Fund Management
Connecticut
$626K +$342K +9,924 +127%
Ensign Peak Advisors
112
Ensign Peak Advisors
Utah
$603K -$205K -5,950 -26%
New York State Common Retirement Fund
113
New York State Common Retirement Fund
New York
$592K -$9.34K -271 -2%
Zurich Cantonal Bank
114
Zurich Cantonal Bank
Switzerland
$572K
Handelsbanken Fonder
115
Handelsbanken Fonder
Sweden
$571K
SCM
116
Semanteon Capital Management
Massachusetts
$564K +$551K +16,001 New
HC
117
Henshaw Capital
Massachusetts
$548K -$122K -3,542 -19%
HSBC Holdings
118
HSBC Holdings
United Kingdom
$535K -$98.1K -2,847 -16%
VI
119
Versor Investments
New York
$534K +$521K +15,135 New
ASRS
120
Arizona State Retirement System
Arizona
$516K +$7.13K +207 +1%
BHCM
121
Brevan Howard Capital Management
Jersey
$480K -$342K -9,922 -42%
TI
122
Tidal Investments
Wisconsin
$474K -$23.5K -682 -5%
BNP Paribas Financial Markets
123
BNP Paribas Financial Markets
France
$474K +$8.23K +239 +2%
PFSRSONJ
124
Police & Firemen's Retirement System of New Jersey
New Jersey
$472K +$81.9K +2,376 +22%
State Board of Administration of Florida Retirement System
125
State Board of Administration of Florida Retirement System
Florida
$469K

ATRC Hedge Fund Activity: Q3 2025 in Review

223 of the 7,620 institutional investors tracked by Wall St. Rank reported a position in AtriCure (ATRC) for Q3 2025, worth a combined $1.7B — up 5.9% from $1.6B a quarter earlier.

Buyers outnumbered sellers: 34 funds opened new ATRC positions and 11 closed out — a net gain of 23 holders — while 70 added to existing stakes and 82 trimmed.

The largest buyer was Massachusetts Financial Services, opening a new position worth an estimated $14.6M. The largest seller was UBS AM, cutting an estimated $21M.

  • 223 institutional investors held AtriCure (ATRC) as of Q3 2025, up from 201 in Q2 2025.
  • Funds reported $1.7B of AtriCure stock for Q3 2025, up 5.9% quarter-over-quarter.
  • 34 funds opened new AtriCure positions in Q3 2025 and 11 closed out, a net change of +23 holders.
  • The largest AtriCure buyer in Q3 2025 was Massachusetts Financial Services, an estimated $14.6M added.
  • The largest AtriCure seller in Q3 2025 was UBS AM, an estimated $21M sold.

Based on aggregated 13F filings for Q3 2025.